Furthermore, phospho-eIF4E plays an important role in bladder cancer progression, and targeting its upstream kinases could be an effective therapeutic option for bladder cancer patients with elevated phospho-eIF4E. This evidence concerns the gene EIF4E and urinary bladder carcinoma.